ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 277 filers reported holding ROYALTY PHARMA PLC in Q1 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,056,560 | -39.9% | 38,930 | -31.9% | 0.69% | -44.0% |
| Q2 2023 | $1,757,713 | -51.9% | 57,180 | -43.7% | 1.24% | -52.3% |
| Q1 2023 | $3,657,045 | -22.3% | 101,500 | -14.8% | 2.60% | -18.2% |
| Q4 2022 | $4,706,042 | -17.1% | 119,080 | -15.7% | 3.18% | -21.3% |
| Q3 2022 | $5,678,000 | -1.1% | 141,305 | +3.4% | 4.04% | +6.1% |
| Q2 2022 | $5,744,000 | +4.2% | 136,635 | -3.5% | 3.80% | +28.1% |
| Q1 2022 | $5,515,000 | -1.4% | 141,560 | +0.8% | 2.97% | +12.0% |
| Q4 2021 | $5,596,000 | +27.5% | 140,435 | +15.6% | 2.65% | +21.3% |
| Q3 2021 | $4,390,000 | -2.5% | 121,485 | +10.6% | 2.19% | +4.3% |
| Q2 2021 | $4,501,000 | -1.6% | 109,805 | +4.7% | 2.10% | -8.1% |
| Q1 2021 | $4,573,000 | -5.7% | 104,835 | +8.2% | 2.28% | -12.6% |
| Q4 2020 | $4,849,000 | +120.6% | 96,885 | +85.5% | 2.61% | +60.0% |
| Q3 2020 | $2,198,000 | – | 52,237 | – | 1.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |